Cardiology
The drug-eluting stent (DES) has dominated the world of device treatment of treatment-naive coronary artery stenosis for two decades, but a study unveiled Nov. 1 may help erode that dominance. One-year data from the TRANSFORM II study suggests that drug-coated balloons (DCBs) may be appropriate for
Cardiology
(Posted Sept. 29, 2026, on LinkedIn) Devices for closure of the left atrial appendage (LAA) have a fascinating history to say the least. These devices have undoubtedly thwarted a large number of strokes in patients with non-valvular atrial fibrillation, but the pharmaceutical industry has moved on from legacy oral
Cardiology
(Posted Sept. 3, 2026, on LinkedIn) Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are anything but the latest thing in the modern cath lab, but cardiologists seem less than unified in their views of their utility. At one end of the debate is a recommendation for extensive use of